About Delfi Diagnostics
Delfi Diagnostics is a private company based in Palo Alto, California. It has reported $365,923,520 raised in five offerings on Form D since August 2019.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 1, 2025 | Dec 18, 2025 | $34,333,315of $60.0M target | 50 | $686K | DebtRule 506(b) | Form D ↗ |
| Jun 10, 2022 | Jul 25, 2022 | $224,999,876fully sold | 44 | $5.1M | EquityRule 506(b) | Form D ↗ |
| Jan 12, 2021 | Jan 27, 2021 | $101,074,986fully sold | 25 | $4.0M | EquityRule 506(b) | Form D ↗ |
| Aug 12, 2019 | Aug 27, 2019 | $5,500,000fully sold | 7 | $785K | EquityRule 506(b) | Form D ↗ |
| Jun 18, 2018 | Aug 13, 2019 | $15,343fully sold | 9 | $1,705 | Common StockRule 506(b) | Form D ↗ |
| Total, five offerings | $365,923,520 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Delfi Diagnostics's Form D filed Dec 18, 2025.
PB
Peter Bach
Executive officer
LF
Lee-Ann Smith-Freeman
Vice President of Legal
VV
Victor Velculescu
Director
ST
Susan Tousi
Executive officer and director
AS
Amoolya Singh
Executive officer
EH
Elizabeth Homans
Director
RG
Rishi Gupta
Director
JN
Jacob Van Naarden
Director
MD
Michael Dybbs
Director
GY
Greg Yap
Director
JK
Justin Kao
Director
Earlier filings also listed Nicholas Dracopoli (executive officer, last listed Jul 2022), Jennifer Buechel (executive officer, last listed Jul 2022), Douglas Schenkel (executive officer, last listed Jul 2022) and William Stevens (executive officer, last listed Jan 2021).